• A40926: From Biosynthetic Precursor to Assay

  2026-09-02

  A40926 is a dalbavancin precursor whose value extends from glycopeptide biosynthesis to rigorous antibacterial assay design. This article connects pathway engineering, D-alanyl-D-alanine target engagement, pathogen-specific MIC interpretation, and translational study planning.

• G007-LK: From Tankyrase Biology to Translation

  2026-09-02

  G007-LK offers translational researchers a mechanistically grounded way to interrogate tankyrase-dependent control of Wnt/β-catenin and Hippo signaling. This article connects biochemical engagement, degradasome formation, APC-mutant colorectal cancer research, and hepatocellular carcinoma evidence to a practical strategy for building more informative preclinical studies.

• Tofacitinib and the RA Macrophage Metabolic Axis

  2026-09-01

  A mechanistic and translational analysis of how Tofacitinib (CP-690550, Tasocitinib) may reshape GM-CSF-reprogrammed rheumatoid arthritis macrophages by coupling cytokine signaling blockade with recovery of mitochondrial function.

• Pterostilbene and Dermal Fibroblast Senescence

  2026-08-31

  Zhou et al. show that pterostilbene reduces senescence phenotypes in human dermal fibroblasts by improving mitochondrial quality and promoting mitophagy. The study connects mitochondrial remodeling with collagen preservation and provides a useful framework for combining senescence, imaging, and respiratory assays in skin-aging research.

• Chlamydial Vesicles Deliver OmpA to Mitochondria

  2026-08-31

  A 2026 PLOS Pathogens study shows that Chlamydia trachomatis-derived membrane vesicles transport the β-barrel protein OmpA to host mitochondria, where it engages BAK and alters BAX localization to suppress apoptosis. The work identifies vesicle-mediated mitochondrial delivery as a coordinated pathogen strategy and provides a mechanistic framework for studying mitochondrial apoptosis across infection and cancer biology.

• Perphenazine: D2 Antagonist Research Workflows

  2026-08-30

  Perphenazine is a dopamine D2 receptor antagonist that supports integrated neuropharmacology, mitochondrial, and host-directed antibacterial assays. This guide translates its receptor profile and reported macrophage activity into practical workflows, controls, and troubleshooting strategies for research laboratories.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-08-29

  The Tricine-SDS-PAGE Gel Preparation Kit is intended for higher-resolution separation of low-molecular-weight proteins and peptides that are difficult to resolve with conventional Tris-glycine PAGE. It is suitable for research workflows using denaturing or non-denaturing conditions, but it is not intended for diagnostic, clinical, or medical applications.

• Synthetic TREM2 Reprograms Macrophage Efferocytosis

  2026-08-29

  Dong et al. engineered a cleavage-resistant TREM2 receptor that preserves DAP12-dependent signaling and macrophage efferocytosis during inflammation. Phosphatidylserine-functionalized lipid nanoparticles delivered CRT mRNA in situ, reducing apoptotic-cell accumulation and inflammatory pathology in mouse models of MASH and atherosclerosis.

• Prevotella copri Depletes IPA in Breast Cancer

  2026-08-28

  The reference study identifies Prevotella copri as a microbiome-associated driver of breast cancer progression that acts by consuming tryptophan and lowering host indole-3-pyruvic acid (IPA). It connects this metabolite depletion to UHRF1-mediated suppression of AMPK, providing a mechanistic framework for studying gut microbiota–metabolite interactions in cancer biology.

• Indole-3-pyruvic acid: Practical Research Workflows

  2026-08-28

  Indole-3-pyruvic acid (IPA) supports complementary workflows in auxin biology, AhR-linked immune studies, and microbiome–cancer research. This guide translates its metabolic role into practical dosing, assay design, handling, and troubleshooting decisions.

• Indole-3-pyruvic acid: Bench-to-Model Workflows

  2026-08-27

  Indole-3-pyruvic acid (IPA) supports two distinct but experimentally connected use cases: tracing auxin biosynthesis in plants and testing AhR-linked immune modulation in mammalian cells and arthritis models. This guide translates the compound’s pathway biology into practical workflows, assay controls, dosing considerations, and troubleshooting steps.

• Astrocyte–Neuron Surface Proteomes in Health and HD

  2026-08-27

  Wu et al. define the cell-surface shared proteome of striatal astrocytes and neurons by combining extracellular HRP proximity labeling with RNA-seq-based assignment of cellular origins. The resulting framework connects astrocyte–neuron molecular interfaces to Huntington’s disease and therapeutic genetic attenuation, while providing a general strategy for studying multicellular brain pathology.

• Making p21 Restoration Translationally Measurable

  2026-08-26

  A thought-leadership perspective on how mechanistic p21 restoration research can be converted into reproducible protein-level evidence using carefully matched HRP immunodetection workflows, with strategic guidance for translational bladder cancer researchers.

• BCL-XL Inhibitor A-1155463: Research Guide

  2026-08-26

  BCL-XL inhibitor A-1155463 is a selective small-molecule tool with a reported Ki of 19 nM and activity in BCL-XL-dependent cancer models. This guide separates product-dossier specifications from peer-reviewed evidence on apoptotic priming, drug resistance in solid tumors, and hematological malignancies research.

• LuQi Formula, SPTLC2, and Post-MI Remodeling

  2026-08-25

  A 2025 Phytomedicine study identifies SPTLC2-regulated de novo ceramide synthesis as a mechanistic link between myocardial infarction and ventricular remodeling. Using rat and cardiomyocyte models, the authors show that LuQi Formula reduces ceramide accumulation and apoptosis while improving post-infarction cardiac function.

453 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page